US Stock MarketDetailed Quotes

RMD ResMed

Watchlist
  • 228.690
  • -0.810-0.35%
Close Dec 31 16:00 ET
  • 228.690
  • 0.0000.00%
Post 16:20 ET
33.57BMarket Cap30.33P/E (TTM)

ResMed Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ResMed Q1 2025 Earnings Date

Currency：USDOct 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.18B
1.22B
+41.58M
Beat Est.
+7.31%
+11.08%
+3.52%
EPS
1.95
2.11
+0.16
Beat Est.
+31.16%
+41.61%
+7.97%
Analyst Rating
Buy

Jan 1, 2025

ResMed Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.298B--
--2025/Q2-- / 1.272B--
Oct 24, 20242025/Q11.225B / 1.183B--
Aug 1, 20242024/Q41.223B / 1.214B--
--2024/Q31.197B / 1.172B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 1.298B--
--2025/Q2-- / 1.272B--
Oct 24, 20242025/Q11.225B / 1.183B--
Aug 1, 20242024/Q41.223B / 1.214B--
--2024/Q31.197B / 1.172B--

Unlock Free Earnings Estimates

ResMed Earnings Reports

  • 10-Q: Q1 2025 Earnings Report

    Oct 25, 2024 16:20 ET

  • 8-K: ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025

    Oct 24, 2024 16:10 ET

  • 10-K: FY2024 Annual Report

    Aug 9, 2024 15:50 ET

  • 8-K: ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

    Aug 1, 2024 16:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 1, 2025

    Buy

    • Buy

      55.56%

    • Hold

      44.44%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data